… for alternative treatment options. Two newer medications (eluxadoline and rifaximin) were
approved in May 2015 for the treatment of IBS-D, and represent new treatment options for this …

… Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder characterized
by abdominal pain and discomfort in association with altered bowel habits. It is estimated to …

… The irritable bowel syndrome (IBS) remains a therapeutic challenge in part because of
the limited understanding of the pathophysiology. The placebo response rate varies in …

… OBJECTIVE To review the evidence supporting selected complementary and alternative
medicine approaches used in the treatment of irritable bowel syndrome (IBS). …

… Specifically, our treatment strategy seems to target constipation, diarrhea, bloating or pain[7]…
treatment. MeSH terms “irritable bowel syndrome treatment” and “IBS treatment” were used …

… Current treatment approaches Irritable bowel syndrome treatment approaches depend on
symptom representation and comorbid conditions such as lifestyle, diet and stress disorders. …

… Irritable bowel syndrome (IBS) is a functional GI disorder that affects a … various pharmacological
treatment options for IBS. … , appears to be a promising treatment option in the pipeline. …

… This article focuses on the clinical evaluation of patients with suspected IBS and treatment
options once the … Evaluation of Manning's criteria in the diagnosis of irritable bowel syndrome. …

… Functional abdominal pain in the context of irritable bowel syndrome (IBS) is a challenging
… non-pharmacological and pharmacological treatment options targeting the central nervous …

Irritable bowel syndrome (IBS) remains a clinical challenge in the 21 st century. It’s the most
commonly diagnosed gastrointestinal condition and also the most common reason for …